WILLIAMS KRISTEN sold $228K of PCRX
WILLIAMS KRISTEN (Chief Administrative Officer) sold 10,259 shares of Pacira BioSciences, Inc. (PCRX) at $22.27 ($0.23M total) on 2026-06-04 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure updates insider activity records but does not introduce new fundamentals (no earnings, trial, approval, or deal information).
Market read
Near-term trading impact is likely limited; any sentiment effect should be weighed against the 10b5-1 pre-arranged nature.
What to watch
Traders may overreact to insider selling; without accompanying buys, guidance changes, or material events, the signal is weak.
Background
SEC Form 4 reports insider transactions; this filing is an officer open-market sale executed under a pre-arranged Rule 10b5-1 plan.
Ticker impact
Pacira BioSciences disclosed an officer open-market sale of 10,259 shares at $22.27 under a 10b5-1 plan.
Low likelihood of a sustained price move; any reaction is likely muted given the stated 10b5-1 pre-arranged plan.
Form 4 shows a scheduled open-market sale by a Chief Administrative Officer; no new operating, regulatory, or financial information is provided.
Market effects
Minimal; single-company insider transaction without new clinical/commercial/regulatory signals.
None indicated.
None indicated.
Counterpoint
10b5-1 sales can be routine liquidity events and may not reflect bearish expectations.
Key entities
- issuerPacira BioSciences, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderKristen Williams
Chief Administrative Officer who sold 10,259 shares under a 10b5-1 plan.
